A new large-scale study tested how artificial intelligence (AI) could improve the detection of breast cancer, and the results showed a notable...
Vous n'êtes pas connecté
A new University of Cincinnati Cancer Center study has identified a particular strand of microRNA as a promising new target for overcoming breast cancer treatment resistance and improving outcomes. The research was recently published in the journal Cancers. Study background The Cancer Center’s Xiaoting Zhang, PhD, said antiestrogen therapy is used for about 75% of breast cancers, but [...]
A new large-scale study tested how artificial intelligence (AI) could improve the detection of breast cancer, and the results showed a notable...
Tumor cells circulating in the blood are the "germ cells" of breast cancer metastases. They are very rare and could not be propagated in the culture...
TUESDAY, Jan. 14, 2025 -- A popular diabetes drug can provide protection against skin cancers, a new study says.Metformin significantly reduces...
FRIDAY, Jan. 10, 2025 -- The machine learning system SCORPIO can predict patient outcomes with immune checkpoint inhibitor (ICI) therapy across...
FRIDAY, Jan. 10, 2025 -- The machine learning system SCORPIO can predict patient outcomes with immune checkpoint inhibitor (ICI) therapy across...
A study co-led by UCLA scientists has found targeting a protein called endocan and its related signaling pathway could be a promising new approach for...
MONDAY, Jan 6, 2025 -- Turns out, starting physical therapy earlier after a concussion may significantly improve recovery outcomes. A new study...
MONDAY, Jan 6, 2025 -- Turns out, starting physical therapy earlier after a concussion may significantly improve recovery outcomes. A new study...
Cardiovascular disease (CVD) and cancer are the two leading causes of death in the United States. A new study by researchers at The University of...
Oral cancer is an increasingly prevalent disease worldwide, with over 300,000 new cases diagnosed each year. Among oral cancers, tongue cancer (TC) is...